Work

Final analysis of a randomized phase II study of bevacizumab (B) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients (pts) with advanced pancreatic cancer (PC)

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.4502

Authors: H. L. Kindler, T. Gangadhar, T. Karrison, H. S. Hochster, M. J. Moore, K. Micetich, W. Sun, D. V. Catenacci, W. M. Stadler, E. E. Vokes

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590893558

Cites:

Cited by: 34

Related to: 10